Butcher's Broom
AsparagaceaeRuscus aculeatus
Also known as: Box Holly, Knee Holly, Pettigree
clinical_notes Clinical Summary
Butcher's Broom (Ruscus aculeatus) is a Mediterranean evergreen shrub whose rhizome yields the steroidal saponins ruscogenin and neoruscogenin, which exert alpha-adrenergic-mediated venous vasoconstriction, reduce capillary permeability and inhibit elastase.
Clinically it is a first-line phytotherapeutic for chronic venous insufficiency, varicose veins, hemorrhoids and orthostatic hypotension — often combined with hesperidin methyl chalcone and vitamin C (Cyclo 3 Fort).
Generally well tolerated short-term; avoid in pregnancy and with alpha-blocker therapy.
Pregnancy Safety
No controlled safety data in pregnancy. Preparations have been informally used for pregnancy-related varicosities, but safety has not been established (Abascal 2005). Avoid except under practitioner supervision.
Lactation Safety
No data on safety during breastfeeding. Steroidal saponins poorly characterized for milk transfer. Avoid without practitioner guidance.
warning Contraindications
- Pregnancy and lactation (caution)Theoretical
- Concurrent alpha-adrenergic antagonist therapy (e.g. prazosin, doxazosin, terazosin, tamsulosin) (caution)Theoretical
- Uncontrolled hypertension (caution)Theoretical
- Poorly controlled diabetes mellitus (caution)Clinically Proven
vital_signs Clinical Profile
Primary Indications
- check_circle Chronic venous insufficiency
- check_circle Varicose veins
- check_circle Hemorrhoids
- check_circle Leg edema
- check_circle Orthostatic hypotension
- check_circle Lymphedema
- check_circle Post-thrombotic syndrome
- check_circle Heavy legs
- check_circle Capillary fragility
Therapeutic Actions
System Affinities
- check_circle Vascular system
- check_circle Lymphatic system
- check_circle Venous system
- check_circle Lower extremities
labs Active Constituents
Ruscogenin
Neoruscogenin
Steroidal saponins
Ruscoside
Flavonoids
Sterols
Benzofurans
Triterpenes
history_edu Traditional Use
No TCM data available for this herb yet.
Traditional Uses Across Healing Systems
While many herbs lack controlled clinical trials, centuries of traditional practice across cultures provide valuable insight into their therapeutic applications.
Venous tonic for chronic venous insufficiency, varicose veins, and hemorrhoids. Approved by German Commission E for supportive therapy of CVI and hemorrhoid complaints.
Revitalized in modern phytotherapy since French research in the 1950s identified ruscogenins.
Historically used as diuretic, mild laxative, and for jaundice. Culpeper and later John Hill (1812) recommended it for gravel, jaundice, and amenorrhea.
The common name derives from butchers binding the stiff twigs into brooms to scrub cutting boards.
spa Parts Used
rhizome
- Chronic venous insufficiency
- Hemorrhoids
- Varicose veins
- Lymphedema
Rhizome is the medicinally active part. Standardize to 9-11% ruscogenins. Dry and grind; typically extracted with methanol or ethanol. ESCOP/Commission E approved for internal use.
shield Safety
Contraindications — Evidence Basis
Pregnancy and lactation
Safety data insufficient; historical use as emmenagogue. Avoid except under practitioner guidance.
Concurrent alpha-adrenergic antagonist therapy (e.g. prazosin, doxazosin, terazosin, tamsulosin)
Ruscogenins are alpha-adrenergic agonists; pharmacodynamic antagonism may reduce efficacy of these agents.
Uncontrolled hypertension
Vasoconstrictive action via alpha-1/alpha-2 adrenergic stimulation may theoretically elevate blood pressure.
Poorly controlled diabetes mellitus
One case report of diabetic ketoacidosis temporally associated with butcher's broom use in a poorly controlled type 1 diabetic.
Monitoring Parameters
Monitor during use, especially with prolonged or high-dose therapy.
Blood pressure
Baseline and every 4 weeks in patients on antihypertensivesAlpha-adrenergic vasoconstrictive action could attenuate antihypertensive efficacy.
flagThreshold: Increase of >10 mmHg systolic warrants reassessment
Toxicity
No established toxic dose; human overdose data lacking. Saponin-rich preparations may cause GI mucosal irritation at high doses.
Nausea, vomiting, abdominal pain, diarrhea. One case report of possible ketoacidosis precipitation in diabetic.
Discontinue; symptomatic GI support; monitor glucose in diabetics.
Adverse Effects
CYP Metabolism
Limited in vitro data. No clinically significant CYP450 interactions documented.
swap_horiz Interactions
Prazosin
Class: Alpha-1 adrenergic antagonist
Butcher's broom is an α-adrenergic agonist that directly activates postjunctional α1- and α2-receptors on venous walls, producing vasoconstriction. This directly antagonizes the pharmacodynamic effect of α1-blockers (prazosin, doxazosin, terazosin, tamsulosin, alfuzosin), potentially reducing their antihypertensive or BPH benefits.
Avoid concurrent use. If combined, monitor blood pressure and BPH symptoms (urinary flow). Consider alternative venotonic in patients requiring alpha-blockade.
Phenylephrine
Class: Alpha-adrenergic agonist (sympathomimetic)
Butcher's broom stimulates release of noradrenaline at the vascular wall and directly activates α1- and α2-adrenoceptors. Combined with sympathomimetic agents (phenylephrine, pseudoephedrine, oxymetazoline, ephedrine), additive vasoconstriction and blood pressure elevation may occur, posing risk of hypertensive crisis in susceptible patients.
Avoid combination with OTC decongestants and sympathomimetic medications. Monitor BP if co-exposure unavoidable. Of particular concern in patients with cardiovascular disease.
Phenelzine
Class: Monoamine oxidase inhibitor (MAOI)
Butcher's broom triggers release of stored norepinephrine from adrenergic nerve endings. MAO inhibitors prevent metabolism of released catecholamines, resulting in greatly elevated synaptic noradrenaline levels, potentially precipitating hypertensive crisis (severe headache, elevated BP, arrhythmias).
Contraindicated with non-selective MAOIs (phenelzine, tranylcypromine) and caution with selective MAO-B (selegiline, rasagiline). Monitor BP closely if any exposure occurs.
Amlodipine
Class: Calcium channel blocker (antihypertensive)
Butcher's broom causes vasoconstriction via α1/α2 receptor activation, which directly antagonizes the vasodilatory effect of calcium channel blockers. May reduce the antihypertensive efficacy of the medication.
Monitor blood pressure regularly. Consider alternative venotonic (e.g., horse chestnut) in hypertensive patients requiring antihypertensive therapy. Avoid in patients with uncontrolled hypertension.
Midodrine
Class: Alpha-1 agonist (orthostatic hypotension)
Butcher's broom and midodrine are both α-adrenergic agonists and both used for orthostatic hypotension. Combined use produces additive vasoconstriction and BP elevation on standing, potentially resulting in supine hypertension (though notably Ruscus alone does not cause supine hypertension).
Monitor standing and supine BP; avoid full-dose combination. Dose reduction of one or both may be appropriate. Monitor for urinary retention, piloerection, and supine hypertension.
Diazoxide
Class: Antihypertensive/vasodilator
Butcher's broom reduces vascular permeability and produces vasoconstriction. Theoretically antagonizes vasodilators used in hypertensive emergencies or hair loss (minoxidil). Clinical significance is modest at typical doses.
Monitor BP response to vasodilator therapy. Consider alternative herb if antihypertensive efficacy is compromised.
hub Combinations
Synergistic pairings can enhance therapeutic outcomes, while knowing suitable substitutes helps when specific herbs are unavailable or contraindicated.
Possible Substitutes
1Yarrow
Traditional UseBoth act as venous/pelvic astringents for hemorrhoids; yarrow is an alternative in patients intolerant of Ruscus saponins.
Traditional Western herbal usage.
Synergistic Combinations
4Bilberry
Limited EvidenceBilberry anthocyanosides strengthen capillary integrity while butcher's broom improves venous tone; synergistic for microvascular disorders and diabetic retinopathy.
Both combined in microvascular support formulas; clinical study of R. aculeatus in nonproliferative diabetic retinopathy showed benefit.
Ginkgo
Limited EvidenceGinkgo improves arterial and cerebral microcirculation; pairs with butcher's broom for overall circulatory support especially in the elderly.
Limited human combination data; commonly used in circulatory blends.
Hawthorn
Traditional UseHawthorn for arterial and cardiac tone combined with butcher's broom for venous tone covers both sides of circulation in patients with cardiovascular weakness and venous stasis.
Traditional European pairing; limited direct evidence for combination.
Horse Chestnut
Moderate EvidenceBoth are venotonics with complementary mechanisms: escin (from horse chestnut) protects hyaluronic acid; ruscogenin inhibits elastase. Together they address connective tissue breakdown in venous walls.
Commonly combined in European CVI formulas; each independently has positive RCT data.
science Studies
Efficacy of Ruscus extract, HMC and vitamin C, constituents of Cyclo 3 fort, on improving individual venous symptoms and edema: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials
Meta-AnalysisThis systematic review and meta-analysis identified 10 randomized, double-blind, placebo-controlled trials (719 patients, mostly low risk of bias) evaluating Ruscus aculeatus-containing preparations for chronic venous disease. Qualitative analysis confirmed significant improvement in all seven defined leg symptoms: pain, heaviness, fatigue, swelling, cramps, itching, and paresthesia. Quantitative meta-analysis showed Ruscus significantly reduced leg pain (RR=0.35, NNT=5), heaviness (RR=0.26, NNT=2.4), paresthesia (RR=0.27, NNT=1.8), and global symptoms (RR=0.54, NNT=4.3) versus placebo. Ankle circumference (SMD=-0.74) and leg volume (SMD=-0.61) were also significantly reduced. The authors graded the existing evidence as high quality, strongly supporting Ruscus extracts as effective treatment for chronic venous disease symptoms and edema.
Combination of Ruscus aculeatus extract, hesperidin methyl chalcone and ascorbic acid: a comprehensive review of their pharmacological and clinical effects and of the pathophysiology of chronic venous disease
Systematic ReviewThis comprehensive review summarized over 50 years of pharmacological and clinical evidence for the Ruscus aculeatus extract combination with hesperidin methyl chalcone (HMC) and ascorbic acid (AA). Preclinical studies demonstrated that ruscogenins from R. aculeatus constrict veins by activating alpha-adrenergic receptors and inhibiting catechol-O-methyl-transferase, reduce capillary permeability, and protect against microcirculatory damage from venous hypertension. Clinical trial data supported benefits in reducing edema, leg symptoms, and improving microcirculation in chronic venous disease. The combination has been used safely in European countries for over 50 years and the review synthesizes the mechanistic basis for its recommendation as a frontline venoactive drug.
medication Dosing
capsule
Standardized extract 7-11 mg ruscogenins equivalent daily (commonly 150 mg extract BID containing ~36-37.5 mg of methanolic dry extract 15-20:1)
1-2 times daily
Approved by ESCOP and German Commission E. Typical regimen 8-12 weeks.
tablet
Combination tablet (Cyclo 3 Fort): 150 mg R. aculeatus + 150 mg hesperidin methyl chalcone + 100 mg ascorbic acid
2-3 tablets daily
Grade 1A recommendation by 2018 European Venous Forum guidelines for CVI symptom relief.
decoction
1.5-3 g dried rhizome per cup
2-3 times daily
Traditional preparation. Simmer 15 min.
topical
Cream applying 64-96 mg extract daily to affected area
Once or twice daily
For hemorrhoids or localized venous complaints. Do not apply to broken or ulcerated skin.
Disclaimer: This information is largely AI-generated and reviewed by human experts at Evara Health. It is intended for educational and clinical reference purposes only and should not replace professional medical advice.
© 2026 Evara Health. All rights reserved.